Bryn Mawr Trust CO Idera Pharmaceuticals, Inc. Transaction History

Bryn Mawr Trust CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 26, 2021	SELL	$1.0 - $1.18 $1,200 - $1,416	-1,200 Reduced 3.54%	32,692 $34,000
Q1 2021 Apr 23, 2021	BUY	$1.23 - $5.98 $5,296 - $25,749	4,306 Added 14.55%	33,892 $44,000
Q4 2020 Feb 11, 2021	BUY	$2.09 - $5.18 $7,202 - $17,850	3,446 Added 13.18%	29,586 $109,000
Q3 2020 Nov 12, 2020	BUY	$1.71 - $2.68 $5,902 - $9,251	3,452 Added 15.22%	26,140 $56,000
Q2 2020 Aug 13, 2020	BUY	$1.23 - $2.12 $9,026 - $15,558	7,339 Added 47.81%	22,688 $41,000
Q1 2020 May 08, 2020	BUY	$1.06 - $2.15 $16,269 - $33,000	15,349 New	15,349 $20,000

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Bryn Mawr Trust CO, based on Form 13F filings with the SEC.

Stay updated on Bryn Mawr Trust CO with notifications on news.